Elevance Health Names Jeff Park President of Carelon

Elevance Health (NYSE: ELV) appointed Jeff Park as President of Carelon, effective December 1, 2026, to lead the business.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/21/2026 - 07:30 AM EDT

Experienced healthcare executive will lead Carelon’s continued evolution and strategic growth

INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health (NYSE: ELV) today announced the appointment of Jeff Park as President of Carelon, effective December 1, 2026. In this role, Park will lead Carelon through its next phase of growth, building on its momentum and expanding its ability to improve affordability, enhance the consumer experience, and create greater value for customers and the people it serves.

Park joins Carelon at a time of significant opportunity as demand continues to grow for integrated solutions that improve affordability, simplify the health care experience, and support better outcomes.

With more than two decades of experience, Park has built, transformed and scaled healthcare services, pharmacy and technology-enabled businesses. Throughout his career, he has successfully led complex integrations, managed large-scale operations and developed innovative solutions addressing complex challenges across the healthcare ecosystem. Most recently, he served as President of Waltz Health and, following Waltz Health's merger with EVERSANA, continued to lead the Waltz business while supporting enterprise growth and strategy initiatives. Previously, Park held senior leadership roles at OptumRx, Catamaran, WellDyneRx and Diplomat Pharmacy.

“Carelon is central to our strategy and an important driver of growth for Elevance Health,” said Gail K. Boudreaux, President and Chief Executive Officer, Elevance Health. “Jeff brings deep healthcare experience and a proven track record of growing businesses, driving execution, and creating value for customers. As we build on Carelon's momentum, his leadership will help accelerate growth, expand our impact, and further our work to make health care more affordable, simpler, and more personalized.”

Carelon brings together its capabilities and trusted partnerships to develop solutions around each person's needs. This connected approach strengthens care coordination and helps consumers and care providers navigate the health care system more effectively.

Under Park’s leadership, Carelon will focus on strengthening operational performance, scaling its solutions and lowering the total cost of care. This work will deepen Carelon’s contribution to Elevance Health and position the business to capture emerging opportunities across the health care ecosystem.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 103 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.